Opportunity Information: Apply for PAR 13 175
Apply for PAR 13 175
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Revision Applications to P01 Awards for Research on Imaging and Biomarkers for Early Cancer Detection (P01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.394 Cancer Detection and Diagnosis Research.
- This funding opportunity was created on Apr 11, 2013 and posted on Apr 11, 2013.
- Applicants must submit their applications by Jul 10, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- Eligible applicants include: For profit organizations other than small businesses City or township governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments Private institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This opportunity, PAR-13-175, is a National Institutes of Health (NIH) discretionary grant announcement that specifically solicits revision (often called competing revision) applications to existing, currently funded NIH P01 Program Project grants. The purpose is not to fund brand-new standalone P01s, but to allow active P01 awardees to expand their ongoing program with an added project that meaningfully extends the parent program while staying aligned with its central scientific theme.
The scientific focus is early cancer detection and diagnosis, with a clear emphasis on approaches that deliberately combine imaging technologies with biomarker strategies. NIH is looking for proposals that integrate multi-modality imaging (for example, combining different imaging platforms or contrasts to improve sensitivity and specificity) together with multiplexed biomarker methodologies (approaches that measure multiple biomarkers at once, such as panels of proteins, nucleic acids, metabolites, or other molecular signals). The underlying idea is that pairing what imaging can show at the tissue or organ level with what biomarkers can reveal at the molecular level could substantially improve screening performance, detect cancers earlier, reduce false positives, and sharpen diagnostic decision-making.
A key structural requirement is that the revision must correspond to an additional project that expands the scope of the parent P01 Program Project. In practical terms, the revision is expected to add a new, well-defined research component rather than simply providing more money for work already approved under the original award. At the same time, NIH underscores that the new project must remain relevant to the overall focus of the existing P01; this is meant to preserve the coherence and integrated nature of the program project mechanism, where multiple projects and cores work together around a shared objective.
From an administrative standpoint, the announcement is categorized as a grant in the health/education domain and is tied to CFDA 93.394 (Cancer Detection and Diagnosis Research). The award ceiling listed is $150,000, and the announcement states there is no cost-sharing or matching requirement. The FOA was posted on April 11, 2013, with an application closing date of July 10, 2013, and it was archived on August 10, 2013, indicating it was a time-limited call.
Eligibility is broad across many U.S.-based organizational types, including public and private institutions of higher education, nonprofits (including both 501(c)(3) and non-501(c)(3) organizations), small businesses and other for-profit organizations (other than small businesses are explicitly listed as eligible as well), and a wide range of governmental entities (state, county, city/township, special districts). The eligibility section also highlights inclusion of various institution types such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISI organizations, as well as faith-based or community-based organizations and eligible federal agencies. Foreign institutions (non-U.S. entities) are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible; however, foreign components as defined under the NIH Grants Policy Statement are allowed, which typically means certain scientifically justified collaborations or elements may be permissible if they meet NIH policy requirements.
For applicants seeking full details, the announcement provides a link to the NIH Grants Guide posting (PAR-13-175). For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster via FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
1) What is PAR-13-175?
PAR-13-175 is a National Institutes of Health (NIH) discretionary grant announcement that solicits revision applications (often called competing revisions) to existing, currently funded NIH P01 Program Project grants.
2) Is this opportunity meant for brand-new P01 Program Project applications?
No. This opportunity is not intended to fund brand-new standalone P01s. It is specifically for applicants who already have an active, currently funded NIH P01 award and want to submit a revision to expand that existing program.
3) What kind of application does NIH want under this announcement?
NIH is looking for a revision application that adds an additional project to an existing P01 Program Project grant. The revision should introduce a new, well-defined research component rather than simply requesting additional funds to continue or enlarge work that was already approved under the parent award.
4) What is the primary scientific focus area?
The scientific focus is early cancer detection and diagnosis, with an emphasis on approaches that deliberately combine imaging technologies with biomarker strategies.
5) What does NIH mean by integrating imaging and biomarker strategies?
The intent is to pair what imaging can show at the tissue or organ level with what biomarkers can reveal at the molecular level, with the goal of improving screening performance, enabling earlier detection, reducing false positives, and improving diagnostic decision-making.
6) What types of imaging approaches are encouraged?
The announcement emphasizes multi-modality imaging, such as combining different imaging platforms or contrasts to improve sensitivity and specificity.
7) What types of biomarker approaches are encouraged?
The announcement emphasizes multiplexed biomarker methodologies, meaning approaches that measure multiple biomarkers at once. Examples noted include panels of proteins, nucleic acids, metabolites, or other molecular signals.
8) What is the key structural requirement for the revision?
The revision must correspond to an additional project that expands the scope of the parent P01 Program Project. It is expected to add a new research component rather than repeating or simply extending previously approved activities.
9) Does the new project have to align with the parent P01?
Yes. NIH underscores that the added project must remain relevant to the overall focus of the existing P01 and stay aligned with the program's central scientific theme, preserving the integrated nature of the program project mechanism.
10) What is the CFDA number associated with this opportunity?
This opportunity is tied to CFDA 93.394, Cancer Detection and Diagnosis Research.
11) What is the award ceiling listed for this announcement?
The award ceiling listed is $150,000.
12) Is cost sharing or matching required?
No. The announcement states there is no cost-sharing or matching requirement.
13) When was the FOA posted, and what were the key dates?
The FOA was posted on April 11, 2013. The application closing date was July 10, 2013. The announcement was archived on August 10, 2013, indicating it was a time-limited call.
14) What types of organizations are eligible to apply?
Eligibility is broad across many U.S.-based organizational types, including public and private institutions of higher education; nonprofits (including both 501(c)(3) and non-501(c)(3) organizations); small businesses; other for-profit organizations (other than small businesses are explicitly listed as eligible as well); and a wide range of governmental entities (state, county, city/township, and special districts).
15) Are minority-serving institutions and specific institution types explicitly included?
Yes. The eligibility section highlights inclusion of HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and AANAPISI organizations. It also notes faith-based or community-based organizations and eligible federal agencies.
16) Can foreign (non-U.S.) institutions apply?
No. Foreign institutions (non-U.S. entities) are not eligible to apply under this announcement.
17) Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are not eligible.
18) Are foreign components allowed at all?
Yes, foreign components as defined under the NIH Grants Policy Statement are allowed. This typically means certain scientifically justified collaborations or elements may be permissible if they meet NIH policy requirements.
19) Where can applicants find the full official announcement details?
The announcement provides a link to the NIH Grants Guide posting for PAR-13-175, which is the source for full details.
20) Who should be contacted for technical access issues related to the announcement?
For technical access issues, the contact listed is the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same category: Education Health
Next opportunity: Revisions to P50 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P50)
Previous opportunity: Revision Applications to U01 Awards on Detection of Pathogen Induced Cancer (DPIC) (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 13 175
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 13 175) also looked into and applied for these:
| Funding Opportunity |
|---|
| Revisions to P50 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P50) Apply for PAR 13 170 Funding Number: PAR 13 170 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Revisions to P01 Awards for Research on Detection of Pathogen Induced Cancer (DPIC) (P01) Apply for PAR 13 171 Funding Number: PAR 13 171 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Paul Calabresi Career Development Award for Clinical Oncology (K12) Apply for PAR 13 201 Funding Number: PAR 13 201 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Symptom Management in HIV Infected Individuals with Comorbid Conditions (R01) Apply for PA 13 210 Funding Number: PA 13 210 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Symptom Management in HIV Infected Individuals with Comorbid Conditions (R21) Apply for PA 13 211 Funding Number: PA 13 211 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Innovative Measurement Tools for Community Engaged Research Efforts (R01) Apply for PA 13 209 Funding Number: PA 13 209 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Innovative Measurement Tools for Community Engaged Research Efforts (R21) Apply for PA 13 212 Funding Number: PA 13 212 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Fogarty HIV Research Training Program for Low and Middle Income Country Institutions (D43) Apply for PAR 13 126 Funding Number: PAR 13 126 Agency: National Institutes of Health Category: Education Health Funding Amount: $282,000 |
| Medications Development Centers of Excellence Cooperative Program (U54) Apply for RFA DA 14 004 Funding Number: RFA DA 14 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R01) Apply for RFA DA 14 005 Funding Number: RFA DA 14 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Substance Use Disorders and Molecular Regulation of Brain Energy Utilization (R21) Apply for RFA DA 14 006 Funding Number: RFA DA 14 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Integration and Analysis of Diverse HIV Associated Data (R03) Apply for RFA MH 14 200 Funding Number: RFA MH 14 200 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NIDA Research Center of Excellence Grant Program (P50) Apply for PAR 13 222 Funding Number: PAR 13 222 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| FY14 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 14 008 Funding Number: RFA DA 14 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Integrating Substance Abuse Prevention and Treatment within HIV/AIDS Service Delivery Settings (R01) Apply for RFA DA 14 011 Funding Number: RFA DA 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| HIV/AIDS and Substance Use among Black/African American Women and Young MSM (R01) Apply for RFA DA 14 010 Funding Number: RFA DA 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| HIV/AIDS and Substance Use Among the Homeless and Unstably Housed (R01) Apply for RFA DA 14 009 Funding Number: RFA DA 14 009 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comorbid HIV, Chronic Pain, and Substance Use among Older Adults (R21) Apply for RFA DA 14 012 Funding Number: RFA DA 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R21) Apply for PA 13 246 Funding Number: PA 13 246 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research to Characterize and Reduce Stigma to Improve Health (R03) Apply for PA 13 247 Funding Number: PA 13 247 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 13 175", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.